Beam Therapeutics Inc. (BEAM) Insider Trading

Last 12 months

Insiders sold $9.7M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. No executive or director has bought shares on the open market in the last two years.

Net open-market

−$9.7M

0 buys · 19 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 6

executives and directors

Last open-market buy

None

in the last two years

Get an email when BEAM's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 15 – 16	John M. Evans CEO	Sold10b5-1 plan 2 parts	50,000	$23.77 average	$1.19M	4.2%	Form 4
Oct 1	Bethany J Cavanagh SVP, Finance and Treasurer	Sold10b5-1 plan	187	$24.41	$5k	0.4%	Form 4
Jul 27	Amy Simon Chief Medical Officer	Sold10b5-1 plan	16,667	$25.74	$429k	16%	Form 4
Jun 30	Amy Simon Chief Medical Officer	Sold10b5-1 plan	373	$34.73	$13k	0.4%	Form 4
Jun 29 – 30	John M. Evans CEO	Sold10b5-1 plan 4 parts	50,000	$34.90 average	$1.74M	4.2%	Form 4
Jun 25 – 26	FMR LLC Large holder	SoldNo plan 2 parts	284,860	$35.24 average	$10M	14%	Form 4
Apr 1	John M. Evans CEO	Sold10b5-1 plan	30,078	$24.58	$739k	2.5%	Form 4
Apr 1	Amy Simon Chief Medical Officer	Sold10b5-1 plan	6,700	$24.58	$165k	6.1%	Form 4
Apr 1	Bethany J Cavanagh SVP, Finance and Treasurer	Sold10b5-1 plan	3,242	$24.58	$80k	6.0%	Form 4
Apr 1	Christine Bellon Chief Legal Officer	Sold10b5-1 plan	5,956	$24.58	$146k	5.1%	Form 4
Apr 1	Giuseppe Ciaramella President	Sold10b5-1 plan	11,810	$24.58	$290k	5.1%	Form 4
Mar 30 – 31	John M. Evans CEO	Sold10b5-1 plan 2 parts	50,000	$22.57 average	$1.13M	4.1%	Form 4
Feb 24	Giuseppe Ciaramella President	Sold10b5-1 plan	35,000	$32.00	$1.12M	16%	Form 4
Jan 29 – 30	John M. Evans CEO	Sold10b5-1 plan 4 parts	50,000	$28.87 average	$1.44M	4.4%	Form 4
Jan 22	Bethany J Cavanagh SVP, Finance and Treasurer	Sold10b5-1 plan	6,198	$35.00	$217k	15%	Form 4
Jan 22	Christine Bellon Chief Legal Officer	Sold10b5-1 plan	1,371	$34.00	$47k	1.4%	Form 4
Jan 20	Bethany J Cavanagh SVP, Finance and Treasurer	Sold10b5-1 plan	3,034	$30.12	$91k	6.9%	Form 4
Jan 15	Christine Bellon Chief Legal Officer	Sold10b5-1 plan 3 parts	18,629	$34.62 average	$645k	16%	Form 4
Dec 31, 2025	Sravan Kumar Emany Chief Financial Officer	Sold10b5-1 plan	6,294	$27.10	$171k	7.9%	Form 4
Dec 31, 2025	Christine Bellon Chief Legal Officer	Sold10b5-1 plan	1,254	$27.10	$34k	1.1%	Form 4
Oct 27, 2025	FMR LLC Large holder	SoldNo plan	459	$26.68	$12k	<0.1%	Form 4
Oct 1, 2025 – Oct 2, 2025	John M. Evans CEO	Sold10b5-1 plan 2 parts	50,000	$24.57 average	$1.23M	4.4%	Form 4
Oct 1, 2025	Bethany J Cavanagh SVP, Finance and Treasurer	Sold10b5-1 plan	467	$24.53	$11k	1.0%	Form 4
Oct 1, 2025	Christine Bellon Chief Legal Officer	Sold10b5-1 plan	373	$24.53	$9k	0.3%	Form 4
Jul 30, 2025	FMR LLC Large holder	SoldNo plan	48,374	$20.50	$992k	1.5%	Form 4
Jul 1, 2025 – Jul 3, 2025	Amy Simon Chief Medical Officer	Sold10b5-1 plan 2 parts	1,250	$19.17 average	$24k	1.9%	Form 4
Apr 1, 2025 – Apr 2, 2025	Amy Simon Chief Medical Officer	Sold10b5-1 plan 2 parts	30,563	$17.92 average	$548k	32%	Form 4
Apr 1, 2025	Christine Bellon Chief Legal Officer	Sold10b5-1 plan	5,674	$18.35	$104k	4.6%	Form 4
Apr 1, 2025	John M. Evans CEO	Sold10b5-1 plan	30,663	$18.35	$563k	2.7%	Form 4
Apr 1, 2025	Giuseppe Ciaramella President	Sold10b5-1 plan	7,434	$18.35	$136k	3.8%	Form 4
Apr 1, 2025	Bethany J Cavanagh SVP, Finance and Treasurer	Sold10b5-1 plan	3,015	$18.35	$55k	6.3%	Form 4
Feb 18, 2025	Bethany J Cavanagh SVP, Finance and Treasurer	Sold10b5-1 plan	6,287	$35.00	$220k	14%	Form 4
Feb 14, 2025	Christine Bellon Chief Legal Officer	Sold10b5-1 plan	10,000	$34.00	$340k	8.9%	Form 4
Jan 2, 2025	Christine Bellon Chief Legal Officer	Sold10b5-1 plan	1,241	$24.68	$31k	1.2%	Form 4
Jan 2, 2025	Bethany J Cavanagh SVP, Finance and Treasurer	Sold10b5-1 plan	1,117	$24.68	$28k	2.5%	Form 4
Nov 6, 2024	Giuseppe Ciaramella President	Sold10b5-1 plan	51,110	$26.36	$1.35M	32%	Form 4

Oct 15 – 1610b5-1 plan
John M. Evans
CEO · sold 50,000 at avg $23.77
$1.19M
4.2% of stake
Oct 110b5-1 plan
Bethany J Cavanagh
SVP, Finance and Treasurer · sold 187 at $24.41
$5k
0.4% of stake
Jul 2710b5-1 plan
Amy Simon
Chief Medical Officer · sold 16,667 at $25.74
$429k
16% of stake
Jun 3010b5-1 plan
Amy Simon
Chief Medical Officer · sold 373 at $34.73
$13k
0.4% of stake
Jun 29 – 3010b5-1 plan
John M. Evans
CEO · sold 50,000 at avg $34.90
$1.74M
4.2% of stake
Jun 25 – 26No plan
FMR LLC
Large holder · sold 284,860 at avg $35.24
$10M
14% of stake
Apr 110b5-1 plan
John M. Evans
CEO · sold 30,078 at $24.58
$739k
2.5% of stake
Apr 110b5-1 plan
Amy Simon
Chief Medical Officer · sold 6,700 at $24.58
$165k
6.1% of stake
Apr 110b5-1 plan
Bethany J Cavanagh
SVP, Finance and Treasurer · sold 3,242 at $24.58
$80k
6.0% of stake
Apr 110b5-1 plan
Christine Bellon
Chief Legal Officer · sold 5,956 at $24.58
$146k
5.1% of stake
Apr 110b5-1 plan
Giuseppe Ciaramella
President · sold 11,810 at $24.58
$290k
5.1% of stake
Mar 30 – 3110b5-1 plan
John M. Evans
CEO · sold 50,000 at avg $22.57
$1.13M
4.1% of stake
Feb 2410b5-1 plan
Giuseppe Ciaramella
President · sold 35,000 at $32.00
$1.12M
16% of stake
Jan 29 – 3010b5-1 plan
John M. Evans
CEO · sold 50,000 at avg $28.87
$1.44M
4.4% of stake
Jan 2210b5-1 plan
Bethany J Cavanagh
SVP, Finance and Treasurer · sold 6,198 at $35.00
$217k
15% of stake
Jan 2210b5-1 plan
Christine Bellon
Chief Legal Officer · sold 1,371 at $34.00
$47k
1.4% of stake
Jan 2010b5-1 plan
Bethany J Cavanagh
SVP, Finance and Treasurer · sold 3,034 at $30.12
$91k
6.9% of stake
Jan 1510b5-1 plan
Christine Bellon
Chief Legal Officer · sold 18,629 at avg $34.62
$645k
16% of stake
Dec 31, 202510b5-1 plan
Sravan Kumar Emany
Chief Financial Officer · sold 6,294 at $27.10
$171k
7.9% of stake
Dec 31, 202510b5-1 plan
Christine Bellon
Chief Legal Officer · sold 1,254 at $27.10
$34k
1.1% of stake
Oct 27, 2025No plan
FMR LLC
Large holder · sold 459 at $26.68
$12k
<0.1% of stake
Oct 1, 2025 – Oct 2, 202510b5-1 plan
John M. Evans
CEO · sold 50,000 at avg $24.57
$1.23M
4.4% of stake
Oct 1, 202510b5-1 plan
Bethany J Cavanagh
SVP, Finance and Treasurer · sold 467 at $24.53
$11k
1.0% of stake
Oct 1, 202510b5-1 plan
Christine Bellon
Chief Legal Officer · sold 373 at $24.53
$9k
0.3% of stake
Jul 30, 2025No plan
FMR LLC
Large holder · sold 48,374 at $20.50
$992k
1.5% of stake
Jul 1, 2025 – Jul 3, 202510b5-1 plan
Amy Simon
Chief Medical Officer · sold 1,250 at avg $19.17
$24k
1.9% of stake
Apr 1, 2025 – Apr 2, 202510b5-1 plan
Amy Simon
Chief Medical Officer · sold 30,563 at avg $17.92
$548k
32% of stake
Apr 1, 202510b5-1 plan
Christine Bellon
Chief Legal Officer · sold 5,674 at $18.35
$104k
4.6% of stake
Apr 1, 202510b5-1 plan
John M. Evans
CEO · sold 30,663 at $18.35
$563k
2.7% of stake
Apr 1, 202510b5-1 plan
Giuseppe Ciaramella
President · sold 7,434 at $18.35
$136k
3.8% of stake
Apr 1, 202510b5-1 plan
Bethany J Cavanagh
SVP, Finance and Treasurer · sold 3,015 at $18.35
$55k
6.3% of stake
Feb 18, 202510b5-1 plan
Bethany J Cavanagh
SVP, Finance and Treasurer · sold 6,287 at $35.00
$220k
14% of stake
Feb 14, 202510b5-1 plan
Christine Bellon
Chief Legal Officer · sold 10,000 at $34.00
$340k
8.9% of stake
Jan 2, 202510b5-1 plan
Christine Bellon
Chief Legal Officer · sold 1,241 at $24.68
$31k
1.2% of stake
Jan 2, 202510b5-1 plan
Bethany J Cavanagh
SVP, Finance and Treasurer · sold 1,117 at $24.68
$28k
2.5% of stake
Nov 6, 202410b5-1 plan
Giuseppe Ciaramella
President · sold 51,110 at $26.36
$1.35M
32% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BEAM, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Biological Products, (No Diagnostic Substances)

IBRXImmunityBio, Inc.

RGNXRegenxbio Inc.

AGENAgenus Inc.

DNAGinkgo Bioworks Holdings Inc.

AUTLAutolus Therapeutics plc

IPSCCentury Therapeutics, Inc.

KYMRKymera Therapeutics Inc.

FDMT4D Molecular Therapeutics, Inc.

Spot a number that looks wrong? Check it in BEAM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BEAM

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.